Granulocyte colony-stimulating factor - A noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease

Circulation Journal

Volumn 70, Issue 9, 2006, Pages 1093-1098

  Arai, Masazumi ^a   Misao, Yu ^a   Nagai, Hiroshi ^a   Kawasaki, Masanori ^a   Nagashima, Kenshi ^a   Suzuki, Koji ^a   Tsuchiya, Kunihiko ^a   Otsuka, Setsuko ^a   Uno, Yoshihiro ^a   Takemura, Genzou ^a   Nishigaki, Kazuhiko ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Bone marrow cells; Granulocyte colony stimulating factor; Limb ischemia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART VENTRICLE FIBRILLATION; HISTOPATHOLOGY; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; REGENERATION;

AGED; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; REGENERATION; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 33748651300     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1093     Document Type: Article

References (25)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Hamano K, Li TS, Kobayashi T, Tanaka N, Kobayashi S, Matsuzaki M, et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: A novel and simple therapeutic method. Surgery 2001; 130: 44-54.
3. Ikenaga S, Hamano K, Nishida M, Kobayashi T, Li TS, Kobayashi S, et al. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res 2001; 96: 277-283.
4. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
5. Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M, et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005; 69: 1260-1265.
6. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Minagawa S, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004; 68: 1189-1193.
7. Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O, et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 1991; 87: 986-995.
8. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-10349.
9. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, et al. Acceleration of the healing process as well as myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by post-infarct G-CSF treatment. Circulation 2004; 109: 2572-2580.
10. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease. Circulation 2001; 104: 2012-2017.
11. Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S, et al. Peripheral blood stem cell mobilization and apheresis: Analysis of adverse events in 94 normal donors. Bone Marrow Transplant 1999; 24: 1065-1071.
12. Horng A, Miller FG. Ethical framework for the use of sham procedures in clinical trials. Crit Care Med 2003; 31: S125-S130.
13. Bensinger WI, Buckner CD, Rowley S, Demirer T, Storb R, Appelbaum FA, et al. Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bone Marrow Transplant 1996; 17: S19-S21.
14. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogenic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3: 45-49.
15. Harada M, Nagafuji K, Fujisaki T, Kubota A, Mizuno S, Takenaka K, et al. G-CSF induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. J Hematother 1996; 5: 63-71.
16. Prosper F, Vanoverbeke K, Stroncek D, Verfaillie CM. Primitive long-term culture initiating cells (LTC-IC) in G-CSF mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICS in steady state bone marrow. Blood 1997; 89: 3991-3997.
17. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36: 601-610.
18. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004; 363: 751-756.
19. Hill JM, Paul JD, Powell TM. Efficacy and risk of granulocyte coronary stimulating factor administration in patients with severe coronary artery disease (abstract). Circulation 2003; 108(Suppl IV): 478.
20. + cells. Circ J 2005; 69: 763-765.
21. Suzuki K, Nagashima K, Arai M, Uno Y, Misao Y, Takemura G, et al. Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease. Circ J 2006; 70: 430-437.
22. Gough A, Clapperton M, Rolando N, Foster AV, Philpott-Howard J, Edmonds ME. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 1997; 350: 855-859.
23. Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 2000; 16: S51-S54.
24. Vargel I, Erdem A, Ertoy D, Pinar A, Erk Y, Altundag MK, et al. Effects of growth factors on doxorubicin-induced skin necrosis: Documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF. Ann Plast Surg 2002; 49: 646-653.
25. Lee M, Aoki M, Kondo T, Kobayashi K, Okumura K, Komori K, et al. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Arterioscler Thromb Vasc Biol 2005; 25: 2535-2541.